Literature DB >> 23270599

Immune system dysregulation in first-onset postpartum psychosis.

Veerle Bergink1, Karin M Burgerhout, Karin Weigelt, Victor J Pop, Harm de Wit, Roos C Drexhage, Steven A Kushner, Hemmo A Drexhage.   

Abstract

BACKGROUND: Accumulating evidence suggests that dysregulation of the immune system represents an important vulnerability factor for mood disorders. Postpartum psychosis (PP) is a severe mood disorder occurring within 4 weeks after delivery, a period of heightened immune responsiveness and an altered endocrine set point. Therefore, the aim of this study was to examine immune activation in patients with first-onset PP at the level of monocytes, T cells, and serum cytokines/chemokines.
METHODS: We included 63 women admitted with first-onset PP. Control groups included healthy postpartum (n = 56) and nonpostpartum (n = 136) women. A quantitative-polymerase chain reaction monocyte gene expression analysis was performed with 43 genes previously identified as abnormally regulated in nonpostpartum mood disorder patients including the isoforms of the glucocorticoid receptor. Peripheral blood mononuclear cells percentages were measured by fluorescence-activated cell sorter analysis, whereas serum cytokines/chemokines were determined with a cytometric bead array.
RESULTS: In healthy women, postpartum T cell levels were significantly elevated compared with nonpostpartum. Patients with PP failed to show the normal postpartum T cell elevation. In contrast, these patients showed a significant elevation of monocyte levels and a significant upregulation of several immune-related monocyte genes compared with control subjects postpartum and nonpostpartum. Furthermore, the glucocorticoid receptor α/β gene expression ratio was decreased in monocytes of PP patients, strongly correlating with their immune activation.
CONCLUSIONS: This study demonstrates a robust dysregulation of the immuno-neuro-endocrine set point in PP, with a notable over-activation of the monocyte/macrophage arm of the immune system.
Copyright © 2013 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23270599     DOI: 10.1016/j.biopsych.2012.11.006

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  27 in total

Review 1.  Maternal programming: Application of a developmental psychopathology perspective.

Authors:  Laura M Glynn; Mariann A Howland; Molly Fox
Journal:  Dev Psychopathol       Date:  2018-08

Review 2.  Recognizing and Managing Postpartum Psychosis: A Clinical Guide for Obstetric Providers.

Authors:  Lauren M Osborne
Journal:  Obstet Gynecol Clin North Am       Date:  2018-09       Impact factor: 2.844

3.  Postpartum psychosis: an important clue to the etiology of mental illness.

Authors:  Ian Jones
Journal:  World Psychiatry       Date:  2020-10       Impact factor: 49.548

Review 4.  Management of New Onset Psychosis in the Postpartum Period.

Authors:  Amanda Tinkelman; Emily A Hill; Kristina M Deligiannidis
Journal:  J Clin Psychiatry       Date:  2017 Nov/Dec       Impact factor: 4.384

5.  Autoimmune Encephalitis in Postpartum Psychosis.

Authors:  Veerle Bergink; Thaís Armangue; Maarten J Titulaer; Sander Markx; Josep Dalmau; Steven A Kushner
Journal:  Am J Psychiatry       Date:  2015-07-17       Impact factor: 18.112

6.  A pilot study on immuno-psychiatry in the 22q11.2 deletion syndrome: A role for Th17 cells in psychosis?

Authors:  Elfi Vergaelen; Carmen Schiweck; Kristof Van Steeland; Jacqueline Counotte; Wim Veling; Ann Swillen; Hemmo Drexhage; Stephan Claes
Journal:  Brain Behav Immun       Date:  2018-03-19       Impact factor: 7.217

Review 7.  Psychiatric consultation to the postpartum mother.

Authors:  Eleanor A Anderson; Deborah R Kim
Journal:  Curr Psychiatry Rep       Date:  2015-04       Impact factor: 5.285

8.  Exaggerated Increases in Microglia Proliferation, Brain Inflammatory Response and Sickness Behaviour upon Lipopolysaccharide Stimulation in Non-Obese Diabetic Mice.

Authors:  Barry McGuiness; Sinead M Gibney; Wouter Beumer; Marjan A Versnel; Inge Sillaber; Andrew Harkin; Hemmo A Drexhage
Journal:  Neuroimmunomodulation       Date:  2016-08-17       Impact factor: 2.492

Review 9.  Neurodegenerative aspects in vulnerability to schizophrenia spectrum disorders.

Authors:  Trevor Archer; Serafino Ricci; Danilo Garcia; Max Rapp Ricciardi
Journal:  Neurotox Res       Date:  2014-05-08       Impact factor: 3.911

10.  Lifetime Exposure to Intimate Partner Violence and Proinflammatory Cytokine Levels Across the Perinatal Period.

Authors:  Emma Robertson Blackmore; Mona Mittal; Xueya Cai; Jan A Moynihan; Monica M Matthieu; Thomas G O'Connor
Journal:  J Womens Health (Larchmt)       Date:  2016-01-08       Impact factor: 2.681

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.